Promising mechanisms, preliminary evidence
The longevity field is genuinely exciting at the cellular level, but it's important to separate mechanism from proof. NAD+ precursors like NMN and nicotinamide riboside (NR) reliably raise NAD+ levels in people, yet human trials on meaningful health or aging outcomes remain small and short. Resveratrol, pterostilbene, spermidine, and fisetin have intriguing lab and animal data, but human longevity evidence is preliminary [2].
What the trials actually show about antioxidants
Many anti-aging products lean on antioxidants. Here the evidence is sobering: large reviews of antioxidant supplements (such as vitamins E and C and beta-carotene) have not shown that they extend lifespan or reduce overall chronic-disease risk, and some high doses were associated with harm [1]. Getting antioxidants from a colorful diet remains the better-supported approach.
The rest of the cabinet
CoQ10, PQQ, alpha-lipoic acid, astaxanthin, quercetin, glutathione, NAC, taurine, and sulforaphane each have their own (mostly early) research stories. Some are well tolerated and reasonable to experiment with; others have meaningful interactions — NAC and glutathione, for example, intersect with several medications. 'Natural' and 'anti-aging' on a label do not mean proven or risk-free [3].
The best-supported longevity 'stack'
The interventions with the strongest links to a longer, healthier life are unglamorous and free: regular physical activity, a mostly-plants diet, adequate sleep, not smoking, moderate or no alcohol, social connection, and managing blood pressure, cholesterol, and blood sugar with a clinician. Supplements are an optional, experimental layer on top — worth approaching with curiosity, realistic expectations, and a conversation with your clinician about interactions [2][3].














